COVEVOL: Natural Evolution at 6 Months of COVID-19
- PMID: 34834958
- PMCID: PMC8619893
- DOI: 10.3390/v13112151
COVEVOL: Natural Evolution at 6 Months of COVID-19
Abstract
Many studies have investigated post-COVID symptoms, but the predictors of symptom persistence remain unknown. The objective was to describe the natural course of the disease at 6 months and to identify possible factors favoring the resurgence or persistence of these symptoms. COVEVOL is a retrospective observational descriptive study of 74 patients. All patients with positive SARS-CoV-2 PCR from March 2020 were included. We compared a group with symptom persistence (PS group) with another group without symptom persistence (no-PS group). Fifty-three out of seventy-four patients (71.62%) described at least one persistent symptom at 6 months of SARS-CoV-2 infection. In the PS group, 56.6% were women and the average age was 54.7 years old [21-89.2] ± 16.9. The main symptoms were asthenia (56.6%, n = 30), dyspnea (34%, n = 18), anxiety (32.1% n = 17), anosmia (24.5%, n = 13) and agueusia (15.1% n = 8). Ten patients (13.51%) presented a resurgence in symptoms. Patients in the PS group were older (p = 0.0048), had a higher BMI (p = 0.0071), and were more frequently hospitalized (p = 0.0359) compared to the no-PS group. Odynophagia and nasal obstruction were less present in the inaugural symptoms of COVID-19 in the PS group (p = 0.0202 and p = 0.0332). Persistent post-COVID syndromes are common and identification of contributing factors is necessary for understanding this phenomenon and appropriate management.
Keywords: anosmia; anxiety; asthenia; dyspnea; persistent symptoms; post-COVID-19; risk factors; “long COVID”.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Allocution Liminaire du Directeur Général de l’OMS Lors du Point Presse sur la COVID-19. 2020. [(accessed on 11 March 2020)]. Available online: https://www.who.int/fr/director-general/speeches/detail/who-director-gen....
-
- Guan W., Liang W., Zhao Y., Liang H., Chen Z., Li Y. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. [(accessed on 10 February 2021)];Eur. Respir. J. 2020 55:2000547. doi: 10.1183/13993003.00547-2020. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/ - DOI - PMC - PubMed
-
- Coronavirus: Chiffres Clés et Évolution de la COVID-19 en France et dans le Monde. [(accessed on 10 February 2021)]. Available online: https://dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolu....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
